News & Press Releases
Filter by:
Members Esteban Morales and Arameh O'Boyle published an article in Bloomberg Law predicting consumer class actions will increase due to evolving state and federal laws affecting telemarketing, online privacy, product labeling, and auto-renewal practices. The authors advise businesses to closely monitor these developments and strengthen arbitration clauses and class action waivers to reduce litigation risk.
Sige Gutman, Life Sciences Litigation Practice Chair, shared insights with IAM in an article about a decision by the US District Court for the District of Delaware which found that a gene therapy patent of RegenxBio and the Trustees of the University of Pennsylvania was ineligible and granted summary judgement in favor of Sarepta Therapeutics.
Bloomberg Law featured Mintz’s addition of the five-partner antitrust litigation team led by Philip Iovieno and including Nicholas Gravante, Jr., Sean O’Shea, Michael Petrella, and Matthew Karlan.
Mintz has again been ranked by Patexia, a leading intellectual property platform, in its Intelligence Report, a comprehensive list of the “best performing” and “most active” ITC Section 337 attorneys and law firms.
Law360 Pulse featured Mintz’s addition of the five-partner antitrust litigation team led by Philip Iovieno and including Nicholas Gravante, Jr., Sean O’Shea, Michael Petrella, and Matthew Karlan.
Mintz has been named a finalist for three awards by LSPN. The awards celebrate excellence across the industry, from trailblazing individuals to firms redefining the boundaries of life sciences IP.
